Trials / Completed
CompletedNCT00232219
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Melbourne Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion. Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion. Cardioversion involves resetting the heart back to normal with the use of electric current. There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion. Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fish oil |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2005-10-04
- Last updated
- 2015-05-05
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00232219. Inclusion in this directory is not an endorsement.